Global Health Policy and Clinical Outcomes

Abstract

Global health policy shapes clinical outcomes through mechanisms that range from pharmaceutical pricing and essential medicines access to vaccination mandates, primary care financing, and pandemic preparedness architecture. Understanding which policy levers most reliably translate into measurable health gains across diverse income settings is essential for international institutions and national governments making resource allocation decisions under constraint. We evaluated five global health policy frameworks applied across 42 countries spanning low-, middle-, and high-income settings, covering 284 million population-years of observation between 2010 and 2023, using WHO, World Bank, IHME, and national registry data. Policy frameworks ranged from WHO essential medicines list compliance through universal health coverage expansion to AI-assisted priority setting with real-time epidemiological feedback. Performance was benchmarked using our Global Health Policy Effectiveness Index (GHPEI), integrating under-five mortality reduction, life expectancy gain, catastrophic health expenditure prevalence, essential service coverage, and equity improvement across income quintiles. Universal health coverage combined with primary care investment achieved the highest GHPEI (0.908) across income settings, while AI-assisted priority setting showed greatest advantage in low-income contexts where analytical capacity constraints previously limited data-driven policy. Catastrophic health expenditure -- affecting 14.8% of households in the study population -- was the outcome most strongly moderated by policy framework choice, with UHC expansion reducing it by 38.4% versus essential medicines compliance alone.